| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/12/2003 | US20030108510 Synergistic mixture of rutin, escin and bufemin; branching of arteries, veins |
| 06/12/2003 | US20030108486 Macrocyclic metal complexes and their use for the production of conjugates with biomolecules |
| 06/12/2003 | US20030107149 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 06/12/2003 | CA2819733A1 Use of selenite-containing compounds to be topically or buccally administered for treating or preventing sunburn |
| 06/12/2003 | CA2819731A1 Use of selenite-containing compounds to be topically or buccally administered for treating an insect bite |
| 06/12/2003 | CA2469356A1 Nuclear protein "shoca" - a component of the wnt signalling pathway |
| 06/12/2003 | CA2469119A1 Pharmaceutical compositions comprising active vitamin d compounds |
| 06/12/2003 | CA2469087A1 Compositions and methods for producing vascular occlusion |
| 06/12/2003 | CA2469082A1 Chimeric molecule for the treatment of th2-like cytokine mediated disorders |
| 06/12/2003 | CA2468672A1 Antimicrobial composition comprising soy oil, rice bran oil and jojoba oil |
| 06/12/2003 | CA2468558A1 "compressed annular tablet with molded triturate tablet for oral and intraoral" |
| 06/12/2003 | CA2468556A1 Cyclodextrin grafted biocompatible amphiphilic polymer and methods of preparation and use thereof |
| 06/12/2003 | CA2468044A1 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith |
| 06/12/2003 | CA2467363A1 Polycistronic expression of antibodies |
| 06/12/2003 | CA2466697A1 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 06/12/2003 | CA2465455A1 Compound |
| 06/12/2003 | CA2465395A1 Transdermal therapeutic systems containing steroid hormones and containing propylene glycol monocaprylate |
| 06/11/2003 | EP1318195A1 A structure for presenting desired peptide sequences |
| 06/11/2003 | EP1317921A1 Gel or solution containing dihydrotestosterone, its manufacture and use |
| 06/11/2003 | EP1317916A2 Films containing modified starch |
| 06/11/2003 | EP1317669A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 06/11/2003 | EP1317556A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug |
| 06/11/2003 | EP1317536A2 Tnf receptor-like molecules and uses thereof |
| 06/11/2003 | EP1317488A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 06/11/2003 | EP1317483A2 Variants of allergenic proteins of the group 2 of dermatophagoides |
| 06/11/2003 | EP1317476A2 Reagents for cell selection and methods of use |
| 06/11/2003 | EP1317439A1 Acid-sensitive compounds, preparation and uses thereof |
| 06/11/2003 | EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents |
| 06/11/2003 | EP1317419A1 Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
| 06/11/2003 | EP1317412A1 Compounds and compositions for delivering active agents |
| 06/11/2003 | EP1317287A2 Polymeric conjugates of antitumor agents |
| 06/11/2003 | EP1317284A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 06/11/2003 | EP1317282A2 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS |
| 06/11/2003 | EP1317273A1 Use of il-6r/il-6 chimera in huntington's disease |
| 06/11/2003 | EP1317272A2 Composition for improving the cell protection comprising a lipophilic antioxidant an a hydrophilic antioxidant |
| 06/11/2003 | EP1317270A1 Exemestane for the treatment of oestrogen-dependent cancers |
| 06/11/2003 | EP1317258A2 Use of agents capable of reducing uric acid levels for the treatment of cardiovascular disease |
| 06/11/2003 | EP1317256A2 Pharmaceutical composition having modified carrier |
| 06/11/2003 | EP1317252A2 Pharmaceutical composition having specific water activity |
| 06/11/2003 | EP1317190A2 Supplement for type 2 diabetes or lipodystrophy |
| 06/11/2003 | EP1284785A4 Medicament-loaded transdermal reservoir and method for its formation |
| 06/11/2003 | EP1228077B1 Ruthenium (ii) complexes with high antitumoral and antimetastatic activities |
| 06/11/2003 | EP1131065B1 Dialkylfumarates for the treatment of autoimmune diseases |
| 06/11/2003 | EP0820270B1 Dispersible particulate system for desensitizing teeth |
| 06/11/2003 | EP0810855B1 Polyalkylene block copolymers as surface modifiers for nanoparticles |
| 06/11/2003 | EP0782863B1 Antibody reagent for detecting dissecting aortic aneurysm and use thereof |
| 06/11/2003 | EP0779894B1 Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces |
| 06/11/2003 | EP0638119B1 Chimeric receptor genes and cells transformed therewith |
| 06/11/2003 | CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex |
| 06/11/2003 | CN1423699A Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 06/11/2003 | CN1423659A Recombinant gelatins |
| 06/11/2003 | CN1423562A Perfusion liquid preparations for ophthalmic operations |
| 06/11/2003 | CN1423559A Controlled-release compositions containing opioid agonist and antagonist |
| 06/11/2003 | CN1423557A Intracorporeal medicaments for photodynamic treatment of disease |
| 06/11/2003 | CN1423556A Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication |
| 06/11/2003 | CN1423555A 掩蔽味道的涂料组合物 Taste-masking coating composition |
| 06/11/2003 | CN1423553A Particulate active agent for pulmonary application |
| 06/11/2003 | CN1422949A Method for producing and converting manioc protoplasm |
| 06/11/2003 | CN1422891A Optimized grain formula |
| 06/11/2003 | CN1422871A Working-resisting low-straight-chain starch dimandioc adipate |
| 06/11/2003 | CN1422671A Medical paste film |
| 06/11/2003 | CN1422668A Medical micro porouse chitoglycan asymmetric film and preparation method thereof |
| 06/11/2003 | CN1422667A Oral liquor composition with reduced bitter taste |
| 06/11/2003 | CN1422619A Lipid composition of high non-soluble platinum matches and lipid body |
| 06/10/2003 | US6576746 Site-specific labeling of disulfide-containing targeting vectors |
| 06/10/2003 | US6576712 Polymer and plasticizing agent are capable of hydrogen or electrostatic bonding to each other and are present in a specific ratio |
| 06/10/2003 | US6576677 Medicinal compositions with relieved bitterness |
| 06/10/2003 | US6576651 Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones |
| 06/10/2003 | US6576649 Method for treating pharmaceutical compositions |
| 06/10/2003 | US6576638 Use of substance P antagonists in the treatment of the adenocarcinomas |
| 06/10/2003 | US6576635 Compositions comprising trimetrexate |
| 06/10/2003 | US6576618 Cholesterol containing cationic liposome having gene encoding insulin like growth factor I |
| 06/10/2003 | US6576270 Herbal composition and medicament against diabetes mellitus type II manufactured thereof |
| 06/10/2003 | US6576266 A mixture of di-O-D-galactosyl-di-O-acylglyceride with phytosphingolipids and phospholipids |
| 06/10/2003 | US6576263 Crosslinked polymer |
| 06/10/2003 | US6576261 Potentiation of inclusion complex formation of cyclodextrin derivatives |
| 06/10/2003 | US6576260 Sustained-release form of administration containing tramadol saccharinate |
| 06/10/2003 | US6576259 Sustained release formulations containing tacrolimus |
| 06/10/2003 | US6576254 Drug delivery, gene therapy |
| 06/10/2003 | US6576252 Composition providing calming, stress hormone regulating and immune stimulation effect, which comprises component including combination of linoleic and linolenic acids in specified ratio, and component taken from flavonoid group |
| 06/10/2003 | US6576245 Primary package containing aqueous solution for parenteral administration comprising low molecular weight peptide-based thrombin inhibitor or salt,and having specified pH, sealed with rubber stopper or plunger containing bromobutyl rubber |
| 06/10/2003 | US6576239 Angiogenic homing molecules and conjugates derived therefrom |
| 06/10/2003 | US6576235 Conjugate of purified uricase, retaining at least about 75% of uricolytic activity of unconjugated uricase and reduced in immunogenicity, in which each subunit of uricase is covalently linked to 2 to 10 strands of polyoxyethylene glycol |
| 06/10/2003 | US6576224 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 06/10/2003 | US6576221 Iron-containing nanoparticles with double coating and their use in diagnosis and therapy |
| 06/10/2003 | US6576220 Non-invasive methods for surgery in the vasculature |
| 06/10/2003 | CA2350195C Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate |
| 06/10/2003 | CA2284753C Throat soothing compositions |
| 06/10/2003 | CA2225286C A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
| 06/10/2003 | CA2225096C Method of applying drug-release coatings |
| 06/10/2003 | CA2216277C Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance |
| 06/10/2003 | CA2176203C Water soluble active sulfones of poly(ethylene glycol) |
| 06/10/2003 | CA2098816C Cosmetic or pharmaceutic composition in the form of a rigid gel, particularly for containing inclusions therein |
| 06/10/2003 | CA2073554C Water-soluble composition for sustained-release |
| 06/10/2003 | CA2065553C Stabilized factor viii preparations |
| 06/05/2003 | WO2003046204A2 Humanized collagen antibodies and related methods |
| 06/05/2003 | WO2003046185A1 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 06/05/2003 | WO2003046047A1 Medical polymers and use thereof |
| 06/05/2003 | WO2003046034A2 Improved synthesis of polyanhyrides |
| 06/05/2003 | WO2003046012A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation |